Alyce Katayama
Professional Bio
Alyce Katayama had more than 30 years of experience representing both institutional and individual clients on a wide range of business issues in the health care industry. She dealt regularly with issues surrounding the 340B Drug Discount Program and the Sunshine Act.
The Message Is Clear from OPA Director Pedley
To Be or Not to 340B Blog ·
340B Covered Entities: What to Expect When OPA Comes Knocking
To Be or Not to 340B Blog ·
340B Program Participants: It’s Time to Ramp Up Compliance
To Be or Not to 340B Blog ·
Controversy Continues to Swirl Around the 340B Program
To Be or Not to 340B Blog ·
The Mega Rule is Dead! Long Live the Interpretive Guidance Documents!
To Be or Not to 340B Blog ·